Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Masellis

Showing results (151-160 of 368) with videos related to

Pageof 37
Sort By:
Translational Stroke Research|November 17, 2018
Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive ImpairmentDi Yu, Marie Hennebelle, Demetrios J Sahlas, et al.
Neurobiology of Aging|March 5, 2019
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementiaTimothy Rittman, Robin Borchert, Simon Jones, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 15, 2023
Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairmentMeng Wang, Tolulope T Sajobi, David B Hogan, et al.
Parkinsonism & Related Disorders|June 27, 2022
Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysisYuen Yan Wong, Che-Yuan Wu, Di Yu, et al.
Brain : a Journal of Neurology|May 19, 2016
Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic studyMario Masellis, Shannon Collinson, Natalie Freeman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 14, 2018
Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI studyRaphael Schneider, Paul McKeever, TaeHyung Kim, et al.
International Psychogeriatrics|March 23, 2017
Development of a decision-making tool for reporting drivers with mild dementia and mild cognitive impairment to transportation administratorsDuncan H Cameron, Carla Zucchero Sarracini, Linda Rozmovits, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2025
Cognitive profiles at presentation and subsequent cognitive decline and quality of life in Parkinson's diseaseSaira S Mirza, Sarah Duff-Canning, Mark Mapstone, et al.
Parkinsonism & Related Disorders|February 23, 2023
Classification and staging of Parkinson's disease using video-based eye trackingDonald C Brien, Heidi C Riek, Rachel Yep, et al.
Trials|July 3, 2024
Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionJoshua M Poulin, Gregory E Bigford, Krista L Lanctôt, et al.
Pageof 37

Showing results (151-160 of 368) with videos related to

Sort By:
Pageof 37
Translational Stroke Research|November 17, 2018
Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive ImpairmentDi Yu, Marie Hennebelle, Demetrios J Sahlas, et al.
Neurobiology of Aging|March 5, 2019
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementiaTimothy Rittman, Robin Borchert, Simon Jones, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 15, 2023
Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairmentMeng Wang, Tolulope T Sajobi, David B Hogan, et al.
Parkinsonism & Related Disorders|June 27, 2022
Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysisYuen Yan Wong, Che-Yuan Wu, Di Yu, et al.
Brain : a Journal of Neurology|May 19, 2016
Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic studyMario Masellis, Shannon Collinson, Natalie Freeman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 14, 2018
Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI studyRaphael Schneider, Paul McKeever, TaeHyung Kim, et al.
International Psychogeriatrics|March 23, 2017
Development of a decision-making tool for reporting drivers with mild dementia and mild cognitive impairment to transportation administratorsDuncan H Cameron, Carla Zucchero Sarracini, Linda Rozmovits, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2025
Cognitive profiles at presentation and subsequent cognitive decline and quality of life in Parkinson's diseaseSaira S Mirza, Sarah Duff-Canning, Mark Mapstone, et al.
Parkinsonism & Related Disorders|February 23, 2023
Classification and staging of Parkinson's disease using video-based eye trackingDonald C Brien, Heidi C Riek, Rachel Yep, et al.
Trials|July 3, 2024
Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionJoshua M Poulin, Gregory E Bigford, Krista L Lanctôt, et al.
Pageof 37